DMC Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-6,597
| Closed | -$358K | – | 121 |
|
2024
Q1 | $358K | Sell |
6,597
-237
| -3% | -$12.9K | 0.31% | 94 |
|
2023
Q4 | $351K | Sell |
6,834
-2,830
| -29% | -$145K | 0.33% | 94 |
|
2023
Q3 | $561K | Sell |
9,664
-466
| -5% | -$27K | 0.53% | 56 |
|
2023
Q2 | $648K | Sell |
10,130
-340
| -3% | -$21.7K | 0.65% | 52 |
|
2023
Q1 | $730K | Hold |
10,470
| – | – | 0.74% | 45 |
|
2022
Q4 | $757K | Sell |
10,470
-435
| -4% | -$31.5K | 0.85% | 37 |
|
2022
Q3 | $769K | Sell |
10,905
-949
| -8% | -$66.9K | 0.93% | 27 |
|
2022
Q2 | $912K | Sell |
11,854
-49
| -0.4% | -$3.77K | 1.08% | 23 |
|
2022
Q1 | $902K | Sell |
11,903
-3,198
| -21% | -$242K | 1.01% | 25 |
|
2021
Q4 | $964K | Buy |
+15,101
| New | +$964K | 0.83% | 28 |
|